Patent Assignment
Reel/Frame 028093/0393
Confirmatory Assignment
Recorded: 2012-04-23
Pages: 3
Assignor
BAYER PHARMA AKTIENGESELLSCHAFT
Executed: 2012-04-23
Assignee
BAYER INTELLECTUAL PROPERTY GMBH
ALFRED-NOBEL-STRASSE 10, MONHEIM, 40789, GERMANY
Covered Properties
(14)
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Patent:
6,362,178 →
Application:
09/554,162 →
2-Phenyl Substituted Imidatriazinones as Phosphodiesterase Inhibitors
Patent:
6,566,360 →
Application:
09/943,530 →
Process for the Preparation of Sulphonamide-Substituted Imidazotriazinones
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Medicaments Containing Vardenafil Hydrochloride Trihydrate
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Process for the Preparation of Sulphonamide-Substituted Imidazotriazinones
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors, for Treatment of Hypertension
Formulations With Controlled Release Of Active Ingredient
Application:
11/579,925 →
Publication:
US 2008/0187588
Pharmaceutical Forms with Improved Pharmacokinetic Properties
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Pde Inhibitors for the Treatment of Hearing Impairment
Application:
12/664,396 →
Publication:
US 2010/0184769
2-Phenyl Substituted Imidazotriazinones as Phosphodiesterase Inhibitors
Application:
13/429,588 →
Publication:
US 2013/0059844
Related Assignments
(4)
Other recorded transfers of the patents in this record — the chain of ownership.
Merger
Jan 12, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 023769/0122 →
Assignment of Assignor's Interest
Apr 23, 2012
From: SANDNER, PETER, DR.; HUTTER, JOACHIM, DR.
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 028089/0158 →
Change of Name
Apr 23, 2012
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: BAYER PHARMA AKTIENGESELLSCHAFT
Reel/Frame 028093/0091 →
Change of Address
Jun 12, 2023
From: BAYER INTELLECTUAL PROPERTY GMBH
To: BAYER INTELLECTUAL PROPERTY GMBH
Reel/Frame 064021/0344 →